Utvidet returrett til 31. januar 2024

Pharma M&A versus alliances and its underlying value drivers

- Are M&A or alliances the right therapy for an ailing pharmaceutical industry?- A capital market perspective

Om Pharma M&A versus alliances and its underlying value drivers

This study analyzes 229 M&A and 120 in-licensing deals in the pharmaceutical industry. The author shows from a capital market perspective that M&A experiences significant, negative cumulative average abnormal returns whereas in-licensings are able to create value. Significant determinants of success for both strategies are derived.

Vis mer
  • Språk:
  • Engelsk
  • ISBN:
  • 9783631663813
  • Bindende:
  • Hardback
  • Sider:
  • 201
  • Utgitt:
  • 28. september 2015
  • Utgave:
  • Dimensjoner:
  • 215x154x17 mm.
  • Vekt:
  • 362 g.
  • BLACK NOVEMBER
  Gratis frakt
Leveringstid: 2-4 uker
Forventet levering: 27. november 2024

Beskrivelse av Pharma M&A versus alliances and its underlying value drivers

This study analyzes 229 M&A and 120 in-licensing deals in the pharmaceutical industry. The author shows from a capital market perspective that M&A experiences significant, negative cumulative average abnormal returns whereas in-licensings are able to create value. Significant determinants of success for both strategies are derived.

Brukervurderinger av Pharma M&A versus alliances and its underlying value drivers



Finn lignende bøker
Boken Pharma M&A versus alliances and its underlying value drivers finnes i følgende kategorier:

Gjør som tusenvis av andre bokelskere

Abonner på vårt nyhetsbrev og få rabatter og inspirasjon til din neste leseopplevelse.